CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance

CVS Health (NYSE: CVS) reported Q3 EPS of $1.97, $0.20 better than the analyst estimate of $1.77. Revenue for the quarter came in at $73.79 billion versus the consensus estimate of $70.4 billion.

GUIDANCE:

CVS Health sees FY2021 EPS of $7.90-$8.00, versus the consensus of $7.79.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c